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Objective: To discuss the changes in the tight junction protein of intestinal epithelium
and permeability of colonic mucosa and its possible mechanism by building the rat mode
of inﬂammatory bowel disease at the chronic recovery stage.
Methods: A total of 36 SD rats were divided into the model group and control one
according to the random number table, with 18 rats in each group. Rats in the model
group were given the 3% dextran sulfate sodium solution by the way of drinking for 7 d
to build the rat model of inﬂammatory bowel disease, while rats in the control group were
given free drinking of water. Six rats were executed at day 7, 14 and 21 respectively. The
colonic tissues were collected from rats to observe the pathological changes of colonic
mucosa. The activity of myeloperoxidase was detected and the white blood count was
performed for rats in each group. The Ussing chamber technique was employed to detect
the transepithelial electrical resistance (TER) and short-circuit current (SC) of colonic
mucosa of rats in different time intervals; the quantum dots labeling technique was
employed to detect the expression level of claudin-1 and claudin-2 in the colonic tissues.
Results: After the successful modeling, the weight of rats in the model group was
signiﬁcantly reduced, while the disease activity index score was increased. The weight
was at the lowest level at day 14 and then it began to increase afterwards. The disease
activity index score was at the highest level at day 12 and then it began to decrease
gradually. The activity of myeloperoxidase and WBC for rats in the model group all
reached the peak value at day 14 and then decreased gradually. There was no signiﬁcant
difference in the changes of TER and SC in different time intervals for rats in the control
group (P > 0.05). TER of model group was at the lowest level at day 14 and then
increased gradually; SC was at the highest level at day 14 and then decreased gradually.
TER of model group at day 7, 14 and 21 was signiﬁcantly lower than that of control
group, while SC of model group was signiﬁcantly higher than that of control group
(P < 0.05). There was no signiﬁcant difference in the change of mean ﬂuorescence in-
tensity of claudin-1 and claudin-2 in different time intervals for rats in the control group
(P > 0.05). The claudin-1 and claudin-2 for rats in the model group reached the highest
level at day 14 and then decreased gradually. The claudin-1 and claudin-2 of model group
at day 7, 14 and 21 was signiﬁcantly higher than that of control group (P < 0.05).
Conclusions: After the acute stage, the inﬂammatory bowel disease is then in the chronic
recovery stage; the increased permeability of colonic mucosa and increased expression of
tight junction protein of intestinal epithelium are closely related to the pathogenesis and
development of disease. The tight junction protein plays a key role in the pathogenesis of
injured colonic barrier of inﬂammatory bowel disease.Afﬁliated to Hubei University of Medicine,
21825).
le under the CC BY-NC-ND license (http://
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The intestinal epithelium is the main defensive barrier of
intestine, which can inhibit the free passing of pathogens, virus
and microorganisms to protect the intestine [1,2]. The tight
junction protein of intestinal epithelium is an important part of
colonic mucosa barrier. After being injured, it will lead to the
increased permeability of colonic mucosa and then make the
microorganisms and toxic substances that cannot pass through
enter in the intestine to induce the inﬂammatory response and
eventually cause the inﬂammatory bowel disease. At present,
there have been a great number of clinical researches on the
mechanism of injured colonic mucosa, including the cytokine
pathway and small guanosine triphosphatase pathway [3,4], but
the ﬁndings are still controversial. In this study, by building
the rat mode of inﬂammatory bowel disease at the chronic
recovery stage, it is to discuss the changes in the tight
junction protein of intestinal epithelium and permeability of
colonic mucosa and the pathogenesis of inﬂammatory bowel
disease, with the ﬁndings shown below.
2. Materials and methods
2.1. Materials
A total of 36 SPF healthy SD rats were purchased from the
laboratory animal center, with equal amount of females and
males, weight of 120–150 g and age of 2–3 months. They were
fed in the cage with the temperature of (22 ± 2) C and relative
humidity of 55%, 12 h day and night alternate. The drinking
water for all rats was treated with high-temperature sterilization.
All rats were treated with fasting, but free water-drinking.
2.2. Instruments and reagents
The dextran sulfate sodium for modeling of colitis was pur-
chased from MPBIO (Item No.: 120317); the myeloperoxidase
was purchased from Shanghai Xin Yu Biotech Co., Ltd; the
rabbit anti-rat claudin-1 and claudin-2 polyclonal antibody was
purchased from Santa Cruz Biotechnology, Inc.; the goat anti-
mouse IgG secondary antibody was purchased from Shanghai
Biovol Technologies Co., Ltd.; Olympus IX70 ﬂuorescence
inverted microscope was adopted.
2.3. Methods
2.3.1. Rat mode of inﬂammatory bowel disease
After 1 week of adaptive feeding, 36 rats were divided into
the model group and control one according to the random
number table, with 18 rats in each group. The animal model was
referred to related literature [5]: The dextran sulfate sodium was
prepared into 3% solution. Rats were fed by the drinking water
for 7 d, then the sterile drinking water at day 8, and then free
drinking water for 14 d. Rats in the control group were given
the sterile drinking water during the whole process. The
general conditions of hair, diet and weight of rats in both
groups were recorded. The rat droppings were collected every
2 d. The fecal occult blood test kit was used to detect the
fecal occult blood fraction and the disease activity index
(DAI) [6] to evaluate the animal growth. Weight: constant
weight as 0 point, weight loss by 1%–5% as 1 point, weightloss by 5%–10% as 2 points, weight loss by 10%–15% as 3
points and weight loss over 15% as 4 points; the normal stool
consistency as 0 point, loose stool as 2 points and diarrhea as
4 points; the normal stool bleeding as 0 point, positive occult
blood as 2 points and revealed hemorrhage as 4 points. The
comprehensive evaluation was performed on these three
conditions and then the total scores of these three results were
divided by 3 to obtain the DAI value, namely DAI = (weight
index + stool form + bleeding situation)/3. Six rats were
selected at day 7, 14 and 21 respectively. After being
anesthetized with 10% chloral hydrate, the colon was sampled
at the place about 2 cm from the anus and then embedded
with the parafﬁn after the ﬁxation using the formaldehyde.
They were sliced into pieces by 5 mm, stained with
hematoxylin-eosin and then observed under the common
microscope.
2.3.2. Detection of myeloperoxidase
The colonic tissues of rats were collected at day 7, 14 and 21
respectively. After the homogenization, they were centrifuged at
15 000 r/min for 10 min. The precipitate was removed and su-
pernatant was collected. According to the instruction manual of
myeloperoxidase kit, it was then incubated at 37 C for 20 min.
Its absorbance was measured at 460 nm and then the enzymatic
activity was calculated. The whole blood was sampled from rats
of two groups in different time intervals by 2 mL. The automatic
biochemical analyzer was employed to detect the white blood
cell (WBC) of rats in each group, with three repeats of mea-
surement. The average of results was than calculated.
2.3.3. Detection of permeability of colonic mucosa
The colonic tissues of rats were collected by about 1 cm at
day 7, 14 and 21 respectively. After separating the muscular
layer and serosal layer, they were ﬁxed in the Ussing chamber.
5 mL sodium chloride solution (0.9%) was added at the side of
mucosa, while 5 mL Kreb buffer at the side of serosa. The whole
device was kept at 37 C and the medium on both sides was
ﬁlled with the mixture of 5% CO2 and 95% O2; the Ussing
chamber technique was employed to detect and record the
transepithelial electrical resistance (TER) and short-circuit cur-
rent (SC) of colonic mucosa of rats.
2.3.4. Detection of expression of tight junction protein
The quantum dots labeling technique was employed to detect
the expression level of claudin-1 and claudin-2 in the colonic
tissues: the colonic tissues was sliced into pieces, then depar-
afﬁned and hydrated normally with the antigen retrieval. It was
washed with TBST buffer 3 times and then incubated in the wet
box at 37 C for 30 min; the claudin-1 and claudin-2 polyclonal
antibodies were added respectively and then it was incubated at
37 C for 3 h; it was washed with TBST buffer 3 times and then
incubated in the wet box at 37 C for 30 min; the goat anti-
mouse IgG secondary antibody was added and it was incu-
bated in the wet box at 37 C for 30 min; it was then washed
with TBST buffer 3 times and incubated in the wet box at 37 C
for 30 min. The streptomycin labeled quantum dots were added
and it was mounted with 50% glycerin; the quantum dots were
excited using different wavelengths under the ﬂuorescence mi-
croscope. It appeared to be positive when the cells with the red-
orange ﬂuorescent particles occurred. The area and ﬂuorescence
intensity of positive cells were measured, while the ﬂuorescence
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referring to the expression of protein. The image pro plus 6.0
was employed to calculate the average ﬂuorescence intensity of
each group.
2.4. Statistical analysis
The SPSS19.0 was used for the statistical analysis. The
clinical data of patients was expressed by mean ± sd. The t test
was adopted for the comparison between two groups, while the
analysis of variance for the comparison among groups and SNK-
q test for the multiple comparison. P < 0.05 referred to the
signiﬁcant difference.
3. Results
3.1. Rat model of inﬂammatory bowel disease
After being treated with the dextran sulfate sodium, rats in
the model group had the symptoms of diarrhea with the purulent
blood and positive occult blood at day 3–5 and they all had the
rectal bleeding at day 5–6; rats appeared to be thin with matt fur,
tired of moving, signiﬁcant loss of diet and water drinking and
weight loss; at day 14, the weight was reduced to the lowest
level and then it began to increase diet and water drinking with
the gradual relief of clinical symptom. DAI score of rats in the
model group was increased from day 2 and it reached to the
highest level at day 12 and then began to decrease gradually; two
of them still had the positive occult blood even at day 21.
3.2. Colonic tissue morphology of rats in both groups
The colonic tissues of rats in the control group had the clear
skin layers and complete mucosal structure; rats in the model
group had the inﬂammatory response at the distal colon and the
mucosal edema at day 7, which indicated the inﬁltration of eo-
sinophils and neutrophils, but only limited to the submucosa;
rats in the model group had the aggravated inﬂammatory
response at day 14 under the microscope, serious necrosis in the
colonic epithelial cells with the crypt disorder and abscess, whileTable 1
Changes of activity of myeloperoxidase and WBC in different time intervals
Group Amount Activity of myeloperoxidase (U/g) F
Day 7 Day 14 Day 21
Model group 6 4.57 ± 0.59 5.29 ± 0.61 3.17 ± 0.31 25.631
Control group 6 0.57 ± 0.11 0.60 ± 0.14 0.58 ± 0.09 0.106
t 16.325 18.356 19.654
P 0.000 0.000 0.000
Table 2
Changes of TER and SC in different time intervals for rats in both groups.
Group Amount TER (U/cm2) F
Day 7 Day 14 Day 21
Model group 6 24.5 ± 6.1 17.9 ± 5.9 28.4 ± 7.3 4.046
Control group 6 46.8 ± 13.1 47.4 ± 12.9 47.1 ± 10.8 0.004
t 3.627 5.094 3.514
P 0.002 0.000 0.003the inﬂammatory cells expanded to the muscular layer; at day
21, the colonic tissues had a great number of crypt disorder with
the inﬁltration of lymphocytes, as well as abundant lymphatic
follicles around the inﬂammatory tissue.
3.3. Changes of activity of myeloperoxidase and WBC in
different time intervals for rats in both groups
The activity of myeloperoxidase and WBC at day 7, 14 and
21 of the model group were all signiﬁcantly higher than that of
the control group at the same time (P < 0.05); while the activity
of myeloperoxidase and WBC of the model group reached to the
highest level at day 14 and then began to decrease gradually
(P < 0.05). There was no signiﬁcant difference in the activity of
myeloperoxidase and WBC of the control group before and after
treatment (P > 0.05), as shown in Table 1.
3.4. Changes of TER and SC in different time intervals
for rats in both groups
There was no signiﬁcant difference in TER and SC in
different time intervals for rats in the control group (P > 0.05).
TER for rats in the model group reached to the lowest level at
day 14 and then it began to increase gradually; while SC reached
to the highest level at day 14 and then decreased gradually; TER
at day 7, 14 and 21 for rats in the model group was signiﬁcantly
lower than that in the control group, while SC was signiﬁcantly
higher than that in the control group (P < 0.05), as shown in
Table 2.
3.5. Average ﬂuorescence intensity of claudin-1 and
claudin-2 in different time intervals for rats in both
groups
There was no signiﬁcant difference in the average ﬂuores-
cence intensity of claudin-1 and claudin-2 in different time in-
tervals for rats in the control group (P > 0.05). The claudin-1
and claudin-2 for rats in the model group reached to the high-
est level at day 14 and then decreased gradually; the claudin-1
and claudin-2 at day 7, 14 and 21 for rats in the model groupfor rats in both groups.
P WBC (×109/L) F P
Day 7 Day 14 Day 21
0.000 17.60 ± 3.40 27.10 ± 5.40 12.90 ± 2.10 20.873 0.000
0.901 4.10 ± 0.80 3.90 ± 0.60 4.20 ± 1.10 0.193 0.829
9.467 10.459 8.989
0.000 0.000 0.000
P SC (mA/cm2) F P
Day 7 Day 14 Day 21
0.039 153.1 ± 21.5 194.4 ± 37.2 143.0 ± 18.9 6.059 0.012




Average ﬂuorescence intensity of claudin-1 and claudin-2 in different time intervals for rats in both groups.
Group Amount Claudin-1 F P Claudin-2 F P
Day 7 Day 14 Day 21 Day 7 Day 14 Day 21
Model group 6 58.3 ± 13.6 79.4 ± 14.8 53.1 ± 12.7 6.177 0.011 67.4 ± 15.30 84.3 ± 17.9 59.4 ± 13.5 3.948 0.042
Control group 6 43.5 ± 10.3 42.2 ± 11.6 41.8 ± 7.9 0.051 0.951 39.7 ± 8.4 41.2 ± 9.7 40.4 ± 8.4 0.043 0.958
t 2.125 4.846 1.851 3.887 5.185 2.927
P 0.030 0.000 0.047 0.002 0.000 0.008
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(P < 0.05), as shown in Table 3.
4. Discussion
According to foreign researches [7,8], the colonic mucosa
played a key role in the pathogenesis of inﬂammatory bowel
disease. The normal colonic mucosa has the tight junction
permeability and its integrity of function can maintain the
normal histomorphology of colonic mucosa to prevent the
invasion of bacteria. The permeability for patients with the
acute inﬂammatory bowel disease may always be increased
because of the injured colonic mucosa and thus the integrity
of intestinal epithelium will be destroyed. Petit et al. [9]
reported that as long as the loss of the tight junction of
intestinal epithelial cells, the permeability of intercellular space
would be increased to make the endotoxin and pathogenic
bacteria enter into the intestine and systemic circulation
through the tight junction. In this study, after the successful
modeling, rats in the model group had the signiﬁcant loss of
weight and increase of DAI score. The weight reached to the
lowest level at day 14 and then it began to increase; while
DAI score reached to the highest level at day 12 and then
decreased gradually, which indicated that rats with the
inﬂammatory bowel disease entered in the chronic recovery
stage after experiencing the acute mucosa injury stage.
Besides, the activity of myeloperoxidase and WBC for rats in
the model group all reached to the highest level at day 14 and
then began to decrease, which proved that rats in the model
group experienced the processes of acute inﬂammation stage
and inﬂammation subsiding, while rats entered in the chronic
recovery stage during the later period. Rao Yanxia et al. [10]
reported that in case of inﬂammation in the colon,
autoimmune of the organism would up-regulate the expression
of tight junction protein and thus recover the function of
mucosal barrier, which was in accordance with the ﬁndings of
this study.
TER was the common physiological index for the evaluation
of transportation rate [11,12] and the detection of TER can
indirectly reﬂect the permeability of barrier. Zhang Jianbin
et al. [13] proved the negative correlation between the cell
permeability and TER, namely the increased permeability of
cells would lead to the decrease of TER, vice versa. Besides,
compared with other indices, TER has the strong speciﬁcity.
SC is the total of all kinds of transmembrane transport of ions,
which can reﬂect the absorption of ions and nutrients by the
epithelial cells [14]. The increased permeability of cells will
lead to the signiﬁcant increase of transportation rate and total
amount of all kinds of ions, showing the increase of SC.
According to the results of this study, TER at day 7, 14 and
21 for the rats in the model group was signiﬁcantly lower than
that in the control group, while SC was signiﬁcantly higherthan that in the control group, which indicated the increased
permeability of colonic mucosa and decreased tight junction of
intestinal epithelium of rats with the inﬂammatory bowel
disease. Wang Bo et al. [15] induced the rats with the
inﬂammatory bowel disease using the bradykinin and found
that the bradykinin could induce the secretion of Cl− to affect
the absorption of Na+ and water and thus result in the changes
of TER and SC. The further results showed that TER for rats
in the model group reached to the lowest level at 14 d and
then it began to be increased; while SC reached to the highest
level at day 14 and then it began to be decreased, which
proved that when being in the chronic recovery stage after the
stage of acute inﬂammation, the permeability of intestinal
epithelial cells was recovered gradually.
The previous researches had proved that the abnormal
expression of claudin was related to the decreased function of
colonic mucosa barrier [16,17], but its speciﬁc mechanism has not
been clear yet. As the important molecular structure of junction
cells, the claudin is the general name of a wide class of proteins.
By now, there have been 23 claudin proteins at least, where the
claudin-1 and claudin-2 are closely related to the inﬂammatory
bowel disease [18,19]. Though the claudin-1 and claudin-2 all
belong to the claudin family, but they have the different func-
tions. The claudin-1 is mainly to close the colonic mucosa and
its upstream regulatory molecule is b-catenin. The claudin-2 is
also named as the pore-forming protein [20] and its increased
expression is one of causes of diarrhea. Besides, many
cytokines are involved in the regulation of claudin-2. Accord-
ing to the results of this study, the claudin-1 and claudin-2 at 7 d,
14 d and 21 d for rats in the model group were all signiﬁcantly
higher than that in the control group, which indicated that the
abnormal expression of tight junction protein was the main
mechanism to cause the reduced function of colonic mucosa
barrier and increased permeability. Rao Yanxia et al. [21] also
detected the abnormal changes of claudin during the active
stage of inﬂammatory bowel disease. The claudin-1 and
claudin-2 for rats in the model group reached to the highest level
at day 14 and then it began to decrease, which indicated that
expression of claudin protein was signiﬁcantly increased in the
stage of acute inﬂammation. After being in the chronic recovery
stage, the expression of claudin was decreased gradually, which
pointed out that the claudin played a key role in the pathogenesis
and prognosis of inﬂammatory bowel disease.
In conclusion, the inﬂammatory bowel disease is in the
chronic recovery stage after the acute stage. The increased
permeability of colonic mucosa and increased expression of tight
junction protein of intestinal epithelium are closely related to the
occurrence and development of the disease. The tight junction
protein plays an important role in the pathogenesis of injured
colonic mucosa barrier of inﬂammatory bowel disease. The
limitation of this study is that the relationship between the
expression of tight junction protein and disease activity was not
Chun-Mei Xu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(2): 148–152152analyzed. Besides, the cause for the tight junction protein to
increase the permeability of colonic mucosa has not been clear
yet, which will be discussed in the further studies.
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